Virax Biolabs Group Ltd. Class A (VRAX) has released an update.
Virax Biolabs Group Ltd. announces that holders of a new Ordinary Share Purchase Warrant can exercise their purchase rights at a price of $5.625 per share, starting from August 23, 2024, until August 21, 2029. The Warrants will be available for exercise through a cash or cashless transaction, with the latter option requiring no effective registration statement for the resale of Warrant Shares. This financial instrument has been issued as part of an Engagement Agreement with H.C. Wainwright & Co., LLC.
For further insights into VRAX stock, check out TipRanks’ Stock Analysis page.
